Youhong Jiang

1.3k total citations
60 papers, 992 citations indexed

About

Youhong Jiang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Youhong Jiang has authored 60 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Youhong Jiang's work include Cancer-related Molecular Pathways (10 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (6 papers). Youhong Jiang is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (6 papers). Youhong Jiang collaborates with scholars based in China, United States and France. Youhong Jiang's co-authors include Chengguang Sui, Fandong Meng, Yuanqin Yin, Ping Ma, Xin Tian, Shenyi Jiang, Yunpeng Liu, Nan Ma, Jingjing Cai and Liye Fu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Youhong Jiang

58 papers receiving 976 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Youhong Jiang 584 272 205 109 91 60 992
Samik Chakraborty 654 1.1× 329 1.2× 281 1.4× 140 1.3× 82 0.9× 37 1.2k
Kui Sheng Chen 606 1.0× 241 0.9× 216 1.1× 97 0.9× 99 1.1× 5 1.0k
Ming‐De Yan 750 1.3× 293 1.1× 136 0.7× 89 0.8× 74 0.8× 27 1.2k
Nasser Samadi 794 1.4× 342 1.3× 249 1.2× 114 1.0× 79 0.9× 31 1.2k
Xiaohong Yang 610 1.0× 183 0.7× 247 1.2× 119 1.1× 71 0.8× 56 1.1k
Neda Shajari 616 1.1× 255 0.9× 148 0.7× 85 0.8× 89 1.0× 14 833
Seunghwan Lim 600 1.0× 151 0.6× 229 1.1× 122 1.1× 71 0.8× 21 874
Bo Lin 521 0.9× 248 0.9× 183 0.9× 86 0.8× 53 0.6× 52 906

Countries citing papers authored by Youhong Jiang

Since Specialization
Citations

This map shows the geographic impact of Youhong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youhong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youhong Jiang more than expected).

Fields of papers citing papers by Youhong Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youhong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youhong Jiang. The network helps show where Youhong Jiang may publish in the future.

Co-authorship network of co-authors of Youhong Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Youhong Jiang. A scholar is included among the top collaborators of Youhong Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youhong Jiang. Youhong Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhao, Yan, et al.. (2024). Progress in the study of molecular mechanisms of intervertebral disc degeneration. Biomedicine & Pharmacotherapy. 174. 116593–116593. 22 indexed citations
3.
Ning, Jing, Shenyi Jiang, Xiaoxi Li, et al.. (2021). GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. BMC Pulmonary Medicine. 21(1). 199–199. 13 indexed citations
4.
Zheng, Jian, Xiaoxi Li, Yong Zhang, et al.. (2021). Higher CD1a Levels Correlate with PD-L1 Expression and Predict Worse Overall Survival in Triple-Negative Breast Carcinoma. Breast Care. 17(1). 31–39. 2 indexed citations
5.
Li, Xiaoxi, Chengguang Sui, Fandong Meng, et al.. (2020). Oleandrin induces apoptosis via activating endoplasmic reticulum stress in breast cancer cells. Biomedicine & Pharmacotherapy. 124. 109852–109852. 24 indexed citations
6.
Wu, Lei, et al.. (2018). miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1. OncoTargets and Therapy. Volume 11. 8773–8781. 20 indexed citations
7.
Yin, Yuanqin, Chengguang Sui, Fandong Meng, Ping Ma, & Youhong Jiang. (2017). The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway. Lipids in Health and Disease. 16(1). 87–87. 70 indexed citations
8.
Tian, Xin, Shun‐Dong Dai, Jing Sun, Shenyi Jiang, & Youhong Jiang. (2016). Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies. Scientific Reports. 6(1). 24097–24097. 22 indexed citations
9.
Li, Yan, Xin Tian, Chengguang Sui, et al.. (2016). Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells. Biomedicine & Pharmacotherapy. 82. 498–508. 17 indexed citations
10.
Meng, Fandong, Shuai Wang, Youhong Jiang, & Chengguang Sui. (2016). Antitumor effect of dendritic cells transfected with prostate-specific membrane antigen recombinant adenovirus on prostate cancer: An in vitro study. Molecular Medicine Reports. 13(3). 2124–2134. 4 indexed citations
11.
Y, Li, Liping Zhou, Ping Ma, et al.. (2014). Relationship of PTTG Expression with Tumor Invasiveness and Microvessel Density of Pituitary Adenomas: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(4). 279–285. 16 indexed citations
12.
Meng, Fandong, Ping Ma, Chengguang Sui, et al.. (2014). The association between VDR polymorphisms and renal cell carcinoma susceptibility: a meta-analysis. Tumor Biology. 35(6). 6065–6072. 8 indexed citations
13.
Meng, Fandong, Yan Li, Xin Tian, et al.. (2014). Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention. Biochemical and Biophysical Research Communications. 453(1). 106–111. 7 indexed citations
14.
Hu, Wei, et al.. (2014). Effects of doxorubicin and gemcitabine on the induction of apoptosis in breast cancer cells. Oncology Reports. 32(6). 2719–2725. 12 indexed citations
15.
Tian, Xin, Ye Tian, Ping Ma, et al.. (2013). Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population. Tumor Biology. 34(5). 2589–2597. 6 indexed citations
16.
17.
Cai, Xue, Weiguo Huang, Yun Qiao, et al.. (2013). Inhibitory effects of curcumin on gastric cancer cells: A proteomic study of molecular targets. Phytomedicine. 20(6). 495–505. 47 indexed citations
19.
Qu, Jinglei, Xiujuan Qu, Jinglei Qu, et al.. (2009). The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells. Acta Oncologica. 48(8). 1173–1180. 40 indexed citations
20.
Liu, Hongbo & Youhong Jiang. (2001). Evaluation of reliability and validity of SF-36 Health Survey in old people in community. 10(3). 244–246. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026